May 31, 2026 by Leo SunThe Real Reason XRP Keeps Bouncing Back -- and What Comes NextHopes for bigger overseas banking partnerships are keeping the token above $1.
May 31, 2026 by Brett SchaferMissed Out on Nvidia? Here's 1 AI Stock You Can Buy Right Now.This major beneficiary of artificial intelligence is flying under investors' radar today.
May 31, 2026 by Reuben Gregg BrewerCapital One's Auto Loan Trends Are Quietly Improving. Why It Matters for the Stock.Capital One tends to lend to higher-risk customers, which can be high-reward and high-risk.
May 31, 2026 by Jeff SiegelNio Just Launched a Budget EV to Take On Tesla and BYD. Is Nio Stock Finally Worth Buying?Lower prices and better margins are changing the Nio story.
May 31, 2026 by Robert IzquierdoIs Gibraltar Industries Stock a Buy After the CEO Purchased Nearly 20,000 Shares?This diversified building products manufacturer attracted insider buying following a sharp one-year share price decline.
May 31, 2026 by Christy BieberHere Are the Average Social Security Benefits at the Most Popular Retirement AgesThere are certain ages when people are more likely to retire. Find out what the average benefit is at each of those ages.
May 31, 2026 by Leo SunThe Real Reason XRP Keeps Bouncing Back -- and What Comes NextHopes for bigger overseas banking partnerships are keeping the token above $1.
May 31, 2026 by Josh Kohn-LindquistFirst Trust (MISL) vs. ARK (ARKX): Which Space and Aerospace ETF Reigns Supreme?Expense ratios, sector weightings, and risk profiles set these two aerospace ETFs apart—see how their strategies shape investor outcomes.
May 31, 2026 by Brett SchaferMissed Out on Nvidia? Here's 1 AI Stock You Can Buy Right Now.This major beneficiary of artificial intelligence is flying under investors' radar today.
May 31, 2026 by Reuben Gregg BrewerCapital One's Auto Loan Trends Are Quietly Improving. Why It Matters for the Stock.Capital One tends to lend to higher-risk customers, which can be high-reward and high-risk.
May 31, 2026 by Robert IzquierdoCRISPR Therapeutics vs. Editas Medicine: Which Gene Editing Stock Is a Better Buy in 2026?One company dominates with an approved therapy, while the other bets on in vivo innovation. See how their financials and risk profiles stack up for 2026.
May 31, 2026 by Adria Cimino7 Billionaires Just Sold Shares of This AI Giant That's Climbed 105,000% Since Its IPO. And 1 Bought the Stock. Which Should You Follow?These expert investors may offer us investing inspiration.
May 31, 2026 by Daniel FoelberBuckle Up, S&P 500 and Nasdaq Index Fund Investors. SpaceX Could Soon Become 1 of Your Largest Positions.Millions of Americans will soon be passively buying SpaceX through their index fund holdings.
May 31, 2026 by Geoffrey SeilerIs Marvell Technology Stock a Buy After Providing a Strong Outlook?Marvell's stock has had a big run this year.
May 31, 2026 by Geoffrey SeilerBetter AI Inference Stock to Own: Nvidia or Cerebras?Both stocks have a big inference opportunity ahead.
May 31, 2026 by Maurie BackmanWant to Grow Your Portfolio Without Any Effort? Buy This ETF and Hold It Till You Retire.It's a super easy way to invest over the long haul.
May 31, 2026 by Cory RenauerKalVista's (KALV) Chief Development Officer Sells 33,800 Shares for $905,000This clinical-stage biotech focused on rare diseases reported a notable insider sale amid a year of strong stock performance.
May 31, 2026 by Kailey Hagen, CFPYour Social Security Checks Could Get a Huge Boost in 2027. How That Could Affect You if You Live in 1 of the 8 States That Taxes Benefits.Some of your COLA might wind up in your state's coffers instead of in your pocket.
May 31, 2026 by Matthew BenjaminDRAM Memory Boom: Why Micron Stock Could Still DoubleMicron's share price doubled in 48 days.
May 31, 2026 by Dominic Basulto1 Top Cryptocurrency to Buy Before It Soars 1,600%, According to Cathie Wood of Ark InvestBitcoin could soar to a price of $1.25 million within the next 5 years.
May 31, 2026 by Reuben Gregg BrewerIs Pfizer Stock a "Value Trap" or a Generational Opportunity?Pfizer is an over-100-year-old drug company going through a rough patch, which has happened before.
May 31, 2026 by James Brumley3 Reasons to Buy Cameco Stock Like There's No TomorrowThe stock's taking a breather after a recent rally, but the company's bright future is likely to manifest sooner rather than later.
May 31, 2026 by Cory RenauerA Progyny (PGNY) Insider Sold 5,500 Shares for $137,000Progyny delivers fertility benefits to major employers; a key insider recently trimmed their stake, according to SEC filings.
